HeimPFIZ34 • BVMF
add
Pfizer BDR
Við síðustu lokun
33,16 R$
Dagbil
32,75 R$ - 33,29 R$
Árabil
30,84 R$ - 43,39 R$
Markaðsvirði
137,81 ma. USD
Meðalmagn
6,06 þ.
Í fréttum
Investing.com
fyrir 6 klukkustundum
UBS initiates 3SBio stock with Buy rating on Pfizer licensing deal
3,42%
0,00%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 13,72 ma. | -7,82% |
Rekstrarkostnaður | 6,30 ma. | -11,72% |
Nettótekjur | 2,97 ma. | -4,75% |
Hagnaðarhlutfall | 21,63 | 3,30% |
Hagnaður á hvern hlut | 0,92 | 12,20% |
EBITDA | 6,44 ma. | -0,02% |
Virkt skatthlutfall | -6,79% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 17,32 ma. | 45,18% |
Heildareignir | 208,03 ma. | -5,91% |
Heildarskuldir | 117,39 ma. | -8,67% |
Eigið fé alls | 90,64 ma. | — |
Útistandandi hlutabréf | 5,69 ma. | — |
Eiginfjárgengi | 2,09 | — |
Arðsemi eigna | 5,72% | — |
Ávöxtun eigin fjár | 7,81% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 2,97 ma. | -4,75% |
Handbært fé frá rekstri | 2,34 ma. | 114,22% |
Reiðufé frá fjárfestingum | 3,27 ma. | 89,03% |
Reiðufé frá fjármögnun | -5,23 ma. | -6,00% |
Breyting á handbæru fé | 374,00 m. | 117,50% |
Frjálst peningaflæði | 1,47 ma. | 283,84% |
Um
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 list. Wikipedia
Framkvæmdastjóri
Stofnsett
1849
Höfuðstöðvar
Vefsvæði
Starfsfólk
81.000
